IQVIA Holdings Inc. (IQV)
NYSE: IQV · Real-Time Price · USD
174.73
-0.96 (-0.55%)
Apr 22, 2026, 3:35 PM EDT - Market open
IQVIA Holdings Revenue
In the year 2025, IQVIA Holdings had annual revenue of $16.31B with 5.87% growth. IQVIA Holdings had revenue of $4.36B in the quarter ending December 31, 2025, with 10.26% growth.
Revenue (ttm)
$16.31B
Revenue Growth
+5.87%
P/S Ratio
1.81
Revenue / Employee
$175,376
Employees
93,000
Market Cap
29.33B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 16.31B | 905.00M | 5.87% |
| Dec 31, 2024 | 15.41B | 421.00M | 2.81% |
| Dec 31, 2023 | 14.98B | 574.00M | 3.98% |
| Dec 31, 2022 | 14.41B | 536.00M | 3.86% |
| Dec 31, 2021 | 13.87B | 2.52B | 22.14% |
| Dec 31, 2020 | 11.36B | 271.00M | 2.44% |
| Dec 31, 2019 | 11.09B | 676.00M | 6.49% |
| Dec 31, 2018 | 10.41B | 710.00M | 7.32% |
| Dec 31, 2017 | 9.70B | 2.89B | 42.36% |
| Dec 31, 2016 | 6.82B | 1.08B | 18.79% |
| Dec 31, 2015 | 5.74B | 277.00M | 5.07% |
| Dec 31, 2014 | 5.46B | 360.45M | 7.07% |
| Dec 31, 2013 | 5.10B | 234.04M | 4.81% |
| Dec 31, 2012 | 4.87B | 537.76M | 12.43% |
| Dec 31, 2011 | 4.33B | 403.73M | 10.29% |
| Dec 31, 2010 | 3.92B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Labcorp Holdings | 13.95B |
| Quest Diagnostics | 11.28B |
| Agilent Technologies | 7.07B |
| Illumina | 4.34B |
| IDEXX Laboratories | 4.30B |
| Mettler-Toledo International | 4.03B |
| Waters | 3.17B |
| Revvity | 2.86B |
IQV News
- 6 days ago - IQVIA to Announce First-Quarter 2026 Results on May 5, 2026 - Business Wire
- 5 weeks ago - IQVIA Unveils IQVIA.ai, a Unified Agentic AI Platform Powered by NVIDIA to Improve Efficiency and Decision Making Across Life Sciences - Business Wire
- 7 weeks ago - IQVIA CFO to Speak at Barclays 28th Annual Global Healthcare Conference - Business Wire
- 7 weeks ago - IQVIA CEO to Speak at Leerink Partners 2026 Global Healthcare Conference - Business Wire
- 7 weeks ago - IQVIA Releases its 2025 Sustainability Report - Business Wire
- 2 months ago - IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities - Business Wire
- 2 months ago - 10 stocks Wall Street expects to roar back after dropping at least 20% in 2026 - Market Watch
- 2 months ago - IQVIA to Speak at Citi's 2026 Unplugged MedTech and Life Sciences Access Day - Business Wire